Corden Pharma Plankstadt

Managing Director:

Johann Mueller

Corden Pharma GmbH

68723 Plankstadt
Phone:+49 6202 99 2299
Fax:+49 6202 99 2000

Get Driving Directions:

Get Directions

>>> Latest News - October 27, 2014 <<< CordenPharma Plankstadt announces today successful results from their latest FDA Inspection: No 483-observations
and no recommendations were reported.


Core Capabilities

  • Manufacturer of solid dosage forms
  • Extensive primary and secondary packaging capacity
  • Special expertise in formulating highly potent products
  • Full range of services including API purification, formulation development, clinical trial supply and pharma-logistics

CordenPharma Plankstadt Facility Capacities

Compliance Approvals

  • FDA – 2014
  • German Authorities - 2014
  • ANVISA - 2009
  • EMEA - 2007

Facility Legacy

Corden Pharma GmbH is an expert manufacturer of solid dosage forms with special expertise in API purification, formulation of highly potent products and a full range of services from pharmaceutical manufacturing to packaging and pharma-logistics (CEE-hub).

As a former operations site of AstraZeneca, CordenPharma Plankstadt brings expertise and extensive capabilities with two facilities for the formulation of solid dosage products, a standard facility for the formulation of  high-volume  non-potent tablets and capsules and a containment facility designed for the manufacturing of non-cytotoxic hormones and hormone blockers.


  • 1970 Rhein-Pharma (Imperial Chemical Industries / Rhein-Chemie) sets up a new production site at Plankstadt
  • Start-up of packing facility
  • 1978 Production is expanded by a new active substance purification facility
  • Start-up of formulation facility
  • 1983 Expansion of the laboratory capacities
  • 2002 Start-up of the high-containment tablet production facility
  • 2007/2008 former AstraZeneca Plankstadt plant acquired by ICIG to become CordenPharma Plankstadt GmbH
  • 2009 Latest FDA Audit